01 1Nanjing Pharmaceutical
01 1BARICITINIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-09-26
Pay. Date : 2025-09-12
DMF Number : 37244
Submission : 2022-08-04
Status : Active
Type : II
20
Nanjing Libravo Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is BARICITINIB, with a corresponding US DMF Number 37244.
Remarkably, this DMF maintains an Active status since its submission on August 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 26, 2025, and payment made on September 12, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
